A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor Administered Subcutaneously to Hypertensive Participants With Controlled Blood Pressure
Clinical trial NCT03714776 · COMPLETED
Trial details
- NCT number
- NCT03714776
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-03
- Primary completion
- 2019-11-13
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.